Two Roads to Generic Drug Profits: The US Niche Strategy vs. India’s Mass Market Model
Two roads to generic drug profits: the US niche strategy vs. India’s mass-market model
Generic drugs are supposed to be the great equalizer—lower prices, wider access, faster competition. But the business of getting there is anything but one-size-fits-…
Two Roads to Generic Drug Profits: The US Niche Strategy vs. India’s Mass Market Model Read Post »
